Concepedia

K. Church

KC

Statistics

Publications

3

Citations

37

H-Index

3

Active since

1994

Affiliations

Baxalta (United States)(Current)

Nationwide Children's Hospital

The Ohio State University

K. Church is an author at Baxalta (United States) specializing in molecular genetics, medicine, and gene-specific therapy.

Publications per year

1994–2017

3

Publications

3

Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness.

Tipu Nazeer, K. Church, C Amato et al. · PubMed · 1994 · 16 citations

, , +8

AVXS-101 phase 1 gene therapy clinical trial in SMA Type 1: end-of-Study event free survival and achievement of developmental milestones

J. Mendell, S. Al-Zaidy, Richard Shell et al. · Neuromuscular Disorders · 2017 · 11 citations

, , +10

AVXS-101 phase 1 gene therapy clinical trial in SMA Type 1: patients treated early with the proposed therapeutic dose were able to sit unassisted at a younger age

Linda Lowes, S. Al-Zaidy, Richard Shell et al. · Neuromuscular Disorders · 2017 · 10 citations

, , +9

1–3 of 3